Related Experiment Videos
[Hypertension in the elderly: particularities and precautions]
1Université Paris-Descartes 5, Département de gériatrie, Hôpital Broca, F-75013 Paris, France. olivier.hanon@wanadoo.fr
Insights
Antihypertensive therapy significantly reduces mortality in elderly patients aged 80 and older. Treatment goals and drug choices for hypertension in older adults should be individualized based on health status and comorbidities.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Context:
- Hypertension is prevalent and often poorly controlled in the elderly population.
- The HYVET study demonstrated benefits of antihypertensive therapy in individuals aged 80+.
- Age-related physiological changes necessitate tailored hypertension management strategies.
Purpose:
- To outline current therapeutic goals for hypertension management in elderly individuals (60-80 years and 80+ years).
- To provide guidance on selecting appropriate antihypertensive medications for older adults.
- To emphasize the importance of monitoring renal function, electrolytes, and cognitive status.
Summary:
- Therapeutic targets for hypertension in the elderly vary by age group: <140/90 mmHg for 60-80 years and <150 mmHg systolic for 80+ years.
- Treatment selection should consider comorbidities, cardiovascular risk, and organ damage, with thiazide diuretics or calcium channel blockers preferred for systolic hypertension.
- Caution is advised regarding polypharmacy, renal risk, and electrolyte imbalances; cognitive function assessment is recommended for those over 80.
Impact:
- Optimized hypertension management can reduce mortality and cardiovascular events in the elderly.
- Individualized treatment plans improve medication adherence and minimize adverse effects.
- This guidance supports clinicians in managing hypertension effectively in a vulnerable patient population.
Abstract:
Hypertension is very common and inadequately controlled among the elderly. The HYVET study showed that antihypertensive therapy significantly reduces total mortality and cardiovascular events in people aged 80 years and older. The therapeutic goal for patients aged from 60 to 80 years is systolic blood pressure (SBP) less than 140 mmHg and a diastolic blood pressure (DBP) less than 90 mmHg, without orthostatic hypotension. For patients older than 80 years, the aim is keep SBP < 150 mmHg. This goal also depends on comorbidities, iatrogenic risk, and life expectancy. The choice of treatment must be adapted to the patient's clinical situation, taking into account any cardiovascular diseases, organ damage, and comorbidities. All of the principal antihypertensive drugs can be used in the elderly, with a preference for thiazide diuretics or calcium channel blockers for those with systolic hypertension. Generally, no more than three antihypertensive drugs should be prescribed for octogenarians (including a thiazide diuretic). Particular attention must be paid to the renal risk (estimated by glomerular filtration rate), especially for nephrotoxic and multiple drugs. Blood levels of potassium, sodium, and creatinine must be monitored in patients receiving diuretics or renin angiotensin system blockers, particularly during acute events (e.g., fever, infection, dehydration, and diarrhea). Cognitive function should be assessed in patients with hypertension older than 80 years, with the MMSE (Mini-Mental-State-Examination) to assess the risk of poor adherence, in view of the increased risk of dementia.
Related Concept Videos
Drug Dosing: Geriatric Patients
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Hypertension V: Nursing Management